Citations 2
Mind the Gap! Working Toward Gender Equity in Pediatric and Congenital Heart Disease: Present and Future
Chowdhury, Devyani , Bansal, Neha , Ansong, Annette , Baker‐Smith, Carissa M. , Choueiter, Nadine , Co‐Vu, Jennifer , Elliott, Pietro , Fuller, Stephanie , Jain, Supriya , Johnson, Jonathan N. , Karamlou, Tara , Kipps, Alaina K. , Laraja, Kristin, Rasheed, Muneera A. , Ronai, Christina , Sachdeva, Ritu , Snyder, Christopher S. , Sutton, Nicole , Stiver, Corey, Shaffer, Kenneth M. , Williams, Roberta G. , Baker-Smith, Carissa M , Co-Vu, Jennifer , Elliott, Pietro , Fuller, Stephanie , Jain, Supriya S , Jone, Pei-Ni , Johnson, Jonathan , Kipps, Alaina K , Lopez, Keila N , Rasheed, Muneera , Ronai, Christina , Sachdeva, Ritu , Snyder, Chris , Sutton, Nicole , Taggart, Nathaniel W , Shaffer, Kenneth , Williams, Roberta , Bauser‐Heaton, Holly , Lopez, Keila N. , Saidi, Arwa S. , Taggart, Nathaniel W.
Journal of the American Heart Association | April 19, 2024 | Volume: 13 | Issue: 9 | Pages: No page available
Evidence from medicine and other fields has shown that gender diversity results in better decision making and outcomes. The incoming workforce of congenital heart specialists (especially in pediatric cardiology) appears to be more gender balanced, but past studies have shown many inequities. Gender‐associated differences in leadership positions, opportunities presented for academic advancement, and recognition for academic contributions to the field persist. In addition, compensation packages remain disparate if evaluated based on gender with equivalent experience and expertise. This review explores these inequities and has suggested individual and institutional changes that could be made to recruit and retain women, monitor the climate of the institution, and identify and eliminate bias in areas like salary and promotions.
Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)
Kiely, David G. , Levin, David L. , Ivy, D. Dunbar , Bwika, Jumaa, Lordan, Jim , Mazurek, Jeremy A. , Moledina, Shahin , Olschewski, Horst , Peacock, Andrew J. , Puri, G. D., Rahaghi, Farbod N. , Schäfer, Michal , Screaton, Nicholas, Noordegraaf, Anton Vonk , Vandepool, Rebecca, Wort, Stephen J. , Zhao, Lan , Wild, Jim M. , Vogel‐Claussen, Jens , Swift, Andrew J. , Vanderpool, Rebecca , Levin, David, Olschewski, Horst , Vonk Noordegraaf, Anton , Vanderpool, Rebecca R , Wild, Jim M , Hassoun, Paul M. , Jone, Pei-Ni , Kawut, Steven M. , Lungu, Angela , Schiebler, Mark , Tawhai, Merryn Howatson , Beek, Edwin J.R. van , Kiely, David , Vogel-Claussen, Jens
Pulmonary Circulation | March 18, 2019 | Volume: 9 | Issue: 3 | Pages: 1-32
Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it remains a life‐shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility, practice remains variable, dependent in part on imaging availability and expertise. This statement summarizes current and emerging imaging modalities and their potential role in the diagnosis and assessment of suspected PH. It also includes a review of commonly encountered clinical and radiological scenarios, and imaging and modeling‐based biomarkers. An expert panel was formed including clinicians, radiologists, imaging scientists, and computational modelers. Section editors generated a series of summary statements based on a review of the literature and professional experience and, following consensus review, a diagnostic algorithm and 55 statements were agreed. The diagnostic algorithm and summary statements emphasize the key role and added value of imaging in the diagnosis and assessment of PH and highlight areas requiring further research.